Next crop of COVID-19 vaccine developers take more traditional route

Many leading candidates now in final-stage testing are based on new, largely unproven technology platforms designed to produce vaccines at speed.

The handful of drugmakers dominating the global coronavirus vaccine race are pushing the boundaries of vaccine technology. The next crop under development feature more conventional, proven designs.